EC
Euclidean Capital Portfolio holdings
AUM
$369M
1-Year Est. Return
26.98%
This Fund
S&P 500
1 Year Est. Return
+26.98%
AUM
$369M
AUM Growth
+$131M
(+55%)
Holding
12
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Vanguard FTSE All-World ex-US ETF
VEU
$57.3B
| $220M | 59.53% |
2,990,084
+411,900
|
|
||
2
Vanguard Value ETF
VTV
$166B
| $99.3M | 26.88% |
+520,000
|
|
||
3
iShares MSCI India ETF
INDA
$8.89B
| $20M | 5.41% |
369,600
|
|
||
4
Foghorn Therapeutics
FHTX
$327M
| $8.5M | 2.3% |
1,573,761
|
|
||
5
Oric Pharmaceuticals
ORIC
$1.52B
| $8.09M | 2.19% |
989,410
|
|
||
6
PMV Pharmaceuticals
PMVP
$81.4M
| $3.28M | 0.89% |
2,627,643
|
|
||
7
State Street SPDR S&P 500 ETF Trust
SPY
$686B
| $2.8M | 0.76% |
4,104
|
|
||
8
RAPT Therapeutics
RAPT
| $2.79M | 0.75% |
82,234
|
|
||
9
Alector
ALEC
$215M
| $2.04M | 0.55% |
1,307,858
|
|
||
10
Surrozen
SRZN
$240M
| $1.98M | 0.54% |
87,696
|
|
||
11
Tenaya Therapeutics
TNYA
$164M
| $723K | 0.2% |
1,015,705
|
|
||
|
12
Surrozen Inc Warrant
SRZNW
| $3.42K | ﹤0.01% |
170,833
|
|